Hepatitis A Vaccine Suppliers & Bulk Manufacturers
Available Forms: Lyophilized powder
Available Strengths: 1 mL doses
Reference Brands: Havrix, Vaqta(US)
Category:
Vaccines
Hepatitis A vaccine stimulates immunity by introducing inactive hepatitis A virus, prompting the body to produce protective antibodies. It prevents hepatitis A infection, reduces disease severity, and curtails transmission. Benefits include lifelong immunity, outbreak control, and protecting vulnerable populations, supporting global efforts to eliminate hepatitis A-related complications.
Hepatitis A Vaccine is available in Lyophilized powder
and strengths such as 1 mL doses.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Hepatitis A Vaccine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Hepatitis A Vaccine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Hepatitis A vaccines are approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA approval involves rigorous clinical evaluation; in the EU, CE marking certifies conformity with in vitro diagnostic and pharmaceutical regulations. These vaccines undergo validation, stability testing, and extensive audits, supported by detailed documentation including safety profiles, clinical efficacy data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective hepatitis A vaccines vital for preventing hepatitis A outbreaks worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing